
Nancy Bitar
Examiner (ID: 18935, Phone: (571)270-1041 , Office: P/2669 )
| Most Active Art Unit | 2664 |
| Art Unit(s) | 2624, 2669, 2664 |
| Total Applications | 1257 |
| Issued Applications | 1017 |
| Pending Applications | 63 |
| Abandoned Applications | 197 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 11499550
[patent_doc_number] => 20170073735
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-03-16
[patent_title] => 'SYSTEMS, METHODS AND SOFTWARE FOR RANKING POTENTIAL GEROPROTECTIVE DRUGS'
[patent_app_type] => utility
[patent_app_number] => 15/125177
[patent_app_country] => US
[patent_app_date] => 2015-03-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 8001
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15125177
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/125177 | SYSTEMS, METHODS AND SOFTWARE FOR RANKING POTENTIAL GEROPROTECTIVE DRUGS | Mar 1, 2015 | Abandoned |
Array
(
[id] => 11663848
[patent_doc_number] => 20170152567
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-06-01
[patent_title] => 'ABERRANT MITOCHONDRIAL DNA, ASSOCIATED FUSION TRANSCRIPTS AND HYBRIDIZATION PROBES THEREFOR'
[patent_app_type] => utility
[patent_app_number] => 14/627755
[patent_app_country] => US
[patent_app_date] => 2015-02-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 61
[patent_figures_cnt] => 61
[patent_no_of_words] => 18221
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14627755
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/627755 | Aberrant mitochondrial DNA, associated fusion transcripts and hybridization probes therefor | Feb 19, 2015 | Issued |
Array
(
[id] => 13154447
[patent_doc_number] => 10093938
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-10-09
[patent_title] => Regulated switch for gene expression
[patent_app_type] => utility
[patent_app_number] => 15/118508
[patent_app_country] => US
[patent_app_date] => 2015-02-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 29
[patent_no_of_words] => 6769
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 94
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15118508
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/118508 | Regulated switch for gene expression | Feb 18, 2015 | Issued |
Array
(
[id] => 11852103
[patent_doc_number] => 20170226595
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-08-10
[patent_title] => 'COMPOSITIONS AND METHODS FOR CONTROLLING CELLULAR FUNCTION'
[patent_app_type] => utility
[patent_app_number] => 15/119506
[patent_app_country] => US
[patent_app_date] => 2015-02-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 38
[patent_figures_cnt] => 38
[patent_no_of_words] => 13919
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15119506
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/119506 | Compositions and methods for controlling cellular function | Feb 17, 2015 | Issued |
Array
(
[id] => 14360721
[patent_doc_number] => 10301648
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-05-28
[patent_title] => Method of increasing the function of an AAV vector
[patent_app_type] => utility
[patent_app_number] => 14/624671
[patent_app_country] => US
[patent_app_date] => 2015-02-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 21
[patent_figures_cnt] => 21
[patent_no_of_words] => 17843
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 89
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14624671
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/624671 | Method of increasing the function of an AAV vector | Feb 17, 2015 | Issued |
Array
(
[id] => 12286891
[patent_doc_number] => 09932624
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-04-03
[patent_title] => Method for recovering sperm nucleic acid from a forensic sample
[patent_app_type] => utility
[patent_app_number] => 14/612183
[patent_app_country] => US
[patent_app_date] => 2015-02-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 11202
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 167
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14612183
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/612183 | Method for recovering sperm nucleic acid from a forensic sample | Feb 1, 2015 | Issued |
Array
(
[id] => 11290805
[patent_doc_number] => 20160340738
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-11-24
[patent_title] => 'NEW FUSION GENE AS THERAPEUTIC TARGET IN PROLIFERATIVE DISEASES'
[patent_app_type] => utility
[patent_app_number] => 15/114003
[patent_app_country] => US
[patent_app_date] => 2015-01-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 18215
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15114003
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/114003 | Fusion gene as therapeutic target in proliferative diseases | Jan 21, 2015 | Issued |
Array
(
[id] => 10254957
[patent_doc_number] => 20150139953
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-05-21
[patent_title] => 'ADENO-ASSOCIATED VIRUS (AAV) SEROTYPE 8 SEQUENCES, VECTORS CONTAINING SAME, AND USES THEREFOR'
[patent_app_type] => utility
[patent_app_number] => 14/598462
[patent_app_country] => US
[patent_app_date] => 2015-01-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 21763
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14598462
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/598462 | Adeno-associated virus (AAV) serotype 8 sequences, vectors containing same, and uses therefor | Jan 15, 2015 | Issued |
Array
(
[id] => 11480718
[patent_doc_number] => 09587250
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-03-07
[patent_title] => 'Adeno-associated virus (AAV) serotype 8 sequences, vectors containing same, and uses therefor'
[patent_app_type] => utility
[patent_app_number] => 14/598477
[patent_app_country] => US
[patent_app_date] => 2015-01-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 21713
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 128
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14598477
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/598477 | Adeno-associated virus (AAV) serotype 8 sequences, vectors containing same, and uses therefor | Jan 15, 2015 | Issued |
Array
(
[id] => 12286765
[patent_doc_number] => 09932582
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-04-03
[patent_title] => Materials and methods for modulation of tendon healing
[patent_app_type] => utility
[patent_app_number] => 15/110108
[patent_app_country] => US
[patent_app_date] => 2015-01-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 8
[patent_no_of_words] => 18391
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 120
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15110108
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/110108 | Materials and methods for modulation of tendon healing | Jan 13, 2015 | Issued |
Array
(
[id] => 11129245
[patent_doc_number] => 20160326220
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-11-10
[patent_title] => 'SECRETION AND FUNCTIONAL DISPLAY OF CHIMERIC POLYPEPTIDES'
[patent_app_type] => utility
[patent_app_number] => 15/108256
[patent_app_country] => US
[patent_app_date] => 2014-12-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 26302
[patent_no_of_claims] => 37
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15108256
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/108256 | SECRETION AND FUNCTIONAL DISPLAY OF CHIMERIC POLYPEPTIDES | Dec 23, 2014 | Abandoned |
Array
(
[id] => 13002367
[patent_doc_number] => 10024845
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-07-17
[patent_title] => Methods for determining modulators of insect transient receptor potential V (TRPV) channel
[patent_app_type] => utility
[patent_app_number] => 15/106872
[patent_app_country] => US
[patent_app_date] => 2014-12-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 113
[patent_figures_cnt] => 127
[patent_no_of_words] => 17255
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 248
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15106872
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/106872 | Methods for determining modulators of insect transient receptor potential V (TRPV) channel | Dec 18, 2014 | Issued |
Array
(
[id] => 13987205
[patent_doc_number] => 20190062760
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-02-28
[patent_title] => Methods and Systems for Autoinduction of Protein Expression
[patent_app_type] => utility
[patent_app_number] => 15/536939
[patent_app_country] => US
[patent_app_date] => 2014-12-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9510
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -27
[patent_words_short_claim] => 45
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15536939
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/536939 | Methods and systems for autoinduction of protein expression | Dec 18, 2014 | Issued |
Array
(
[id] => 11115320
[patent_doc_number] => 20160312294
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-10-27
[patent_title] => 'PROSTATE CANCER CLASSIFICATION'
[patent_app_type] => utility
[patent_app_number] => 15/103770
[patent_app_country] => US
[patent_app_date] => 2014-12-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 22819
[patent_no_of_claims] => 49
[patent_no_of_ind_claims] => 32
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15103770
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/103770 | Prostate cancer classification | Dec 11, 2014 | Issued |
Array
(
[id] => 10291089
[patent_doc_number] => 20150176088
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-06-25
[patent_title] => 'ASSAY FOR IDENTIFYING COMPOUNDS WHICH AFFECT STABILITY OF MRNA'
[patent_app_type] => utility
[patent_app_number] => 14/566621
[patent_app_country] => US
[patent_app_date] => 2014-12-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 18
[patent_no_of_words] => 17233
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14566621
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/566621 | ASSAY FOR IDENTIFYING COMPOUNDS WHICH AFFECT STABILITY OF MRNA | Dec 9, 2014 | Abandoned |
Array
(
[id] => 15163291
[patent_doc_number] => 10487125
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-11-26
[patent_title] => Ice structuring protein
[patent_app_type] => utility
[patent_app_number] => 15/039110
[patent_app_country] => US
[patent_app_date] => 2014-12-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 12819
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 71
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15039110
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/039110 | Ice structuring protein | Dec 1, 2014 | Issued |
Array
(
[id] => 11421651
[patent_doc_number] => 20170029794
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-02-02
[patent_title] => 'TAL EFFECTOR MEANS USEFUL FOR PARTIAL OR FULL DELETION OF DNA TANDEM REPEATS'
[patent_app_type] => utility
[patent_app_number] => 15/039393
[patent_app_country] => US
[patent_app_date] => 2014-11-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 35984
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 17
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15039393
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/039393 | TAL EFFECTOR MEANS USEFUL FOR PARTIAL OR FULL DELETION OF DNA TANDEM REPEATS | Nov 25, 2014 | Abandoned |
Array
(
[id] => 11597062
[patent_doc_number] => 09644216
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-05-09
[patent_title] => 'Adeno-associated virus vectors for treatment of glycogen storage disease'
[patent_app_type] => utility
[patent_app_number] => 15/038979
[patent_app_country] => US
[patent_app_date] => 2014-11-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 29
[patent_no_of_words] => 17710
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 24
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15038979
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/038979 | Adeno-associated virus vectors for treatment of glycogen storage disease | Nov 24, 2014 | Issued |
Array
(
[id] => 11092793
[patent_doc_number] => 20160289762
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-10-06
[patent_title] => 'METHODS FOR PROFILIING AND QUANTITATING CELL-FREE RNA'
[patent_app_type] => utility
[patent_app_number] => 15/034746
[patent_app_country] => US
[patent_app_date] => 2014-11-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 37
[patent_figures_cnt] => 37
[patent_no_of_words] => 27633
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15034746
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/034746 | METHODS FOR PROFILIING AND QUANTITATING CELL-FREE RNA | Nov 5, 2014 | Abandoned |
Array
(
[id] => 11270807
[patent_doc_number] => 20160333355
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-11-17
[patent_title] => 'ANTI-TUMOR THERAPY'
[patent_app_type] => utility
[patent_app_number] => 15/109945
[patent_app_country] => US
[patent_app_date] => 2014-10-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 29
[patent_figures_cnt] => 29
[patent_no_of_words] => 33276
[patent_no_of_claims] => 63
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15109945
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/109945 | Anti-tumor therapy | Oct 23, 2014 | Issued |